Searching for the Noninvasive Biomarker Holy Grail: Are Urine Proteomics the Answer?

Biological Research for Nursing

Volumn 13, Issue 3, 2011, Pages 235-242

  Voss, Joachim ^a   Goo, Young Ah ^a   Cain, Kevin ^a   Woods, Nancy ^a   Jarrett, Monica ^a   Smith, Lynne ^a   Shulman, Robert ^b   Heitkemper, Margaret ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

irritable bowel syndrome; mass spectrometry; proteomics; urine

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL NURSING RESEARCH; HUMAN; IRRITABLE COLON; MASS SPECTROMETRY; METHODOLOGY; NURSING; PROTEOMICS; REVIEW; URINE;

BIOLOGICAL MARKERS; CLINICAL NURSING RESEARCH; HUMANS; IRRITABLE BOWEL SYNDROME; MASS SPECTROMETRY; PROTEOMICS;

EID: 79959538458     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800411402056     Document Type: Review

References (53)

1. Adachi, J., Kumar, C., Zhang, Y., Olsen, J.V., & Mann, M. (2006). The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biology, 7, R80.
2. Afkarian, M., Bhasin, M., Dillon, S.T., Guerrero, M.C., Nelson, R.G., Knowler, W.C., Libermann, T. A. (2010). Optimizing a proteomics platform for urine biomarker discovery. Molecular & Cellular Proteomics, 9, 2195-2204.
3. Apweiler, R., Aslanidis, C., Deufel, T., Gerstner, A., Hansen, J., Hochstrasser, D., & Schmitz, G. (2009). Approaching clinical proteomics: Current state and future fields of application in cellular proteomics. Cytometry. Part A: the Journal of the International Society for Analytical Cytology, 75, 816-832.
4. Breedlove, G., & Busenhart, T. (2005). Screening and detection of ovarian cancer. Journal of Midwifery & Women's Health, 50, 51-54.
5. Buhimschi, I.A., Zhao, G., Funai, E.F., Harris, N., Sasson, I.E., Bernstein, I.M.,.Buhinski, G.R. (2008). Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. American Journal of Obstetrics and Gynecology, 199, 551.e1-551.e16.
6. Burr, R.L., Jarrett, M.E., Cain, K.C., Jun, S.E., & Heitkemper, M.M. (2009). Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome. Neurogastroenterology and Motility, 21, 1148-1197.
7. Cain, K.C., Jarrett, M.E., Burr, R.L., Rosen, S., Hertig, V.L., & Heitkemper, M.M. (2009). Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Digestive Diseases and Sciences, 54, 1542-1549.
8. Carey, L.A. (2010). Through a glass darkly: Advances in understanding breast cancer biology, 2000-2010. Clinical Breast Cancer, 10, 188-195.
9. Christensen, E., Evans, K.R., Menard, C., Pintille, M., & Bristow, R.G. (2008). Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials. Cancer and Metastasis Reviews, 27, 375-385.
10. Chua, W., Moore, M.M., Charles, K.A., & Clarke, S.J. (2009). Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer. Current Opinions in Molecular Therapies, 11, 611-622.
11. Chuang, P.Y., Conley, Y.P., Poloyac, S.M., Okonkwo, D.O., Ren, D., Sherwood, P.R., Alexander, S. A. (2010). Neuroglobin genetic polymorphisms and their relationship to functional outcomes after traumatic brain injury. Journal of Neurotrauma, 27, 999-1006.
12. Decramer, S., Gonzalez de Peredo, A., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.L., & Schanstra, J.P. (2008). Urine in clinical proteomics. Molecular & Cellular Proteomics, 7, 1850-1862.
13. Ding, Y., Lu, B., Chen, D., Meng, L., Shen, Y., Chen, S., & Lu, B. (2010). Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics, 10, 2620-2630. doi:10.1002/ pmic.200900572.
14. Drossman, D.A., Camilleri, M., Mayer, E.A., & Whitehead, W.E. (2002). AGA technical review on irritable bowel syndrome. Gastroenterology, 123, 2108-2131.
15. Dudley, J.T., & Butte, A.J. (2009). Identification of discriminating biomarkers for human disease using integrative network biology. Pacific Symposium of Biocomputing, 27-38.
16. Founds, S.A. (2009). Introducing systems biology for nursing science. Biological Research for Nursing, 11, 73-80.
17. Gilmore, J.M., & Washburn, M.P. (2010). Advances in shotgun proteomics and the analysis of membrane proteomes. Journal of Proteomics, 73, 2078-2091. doi:10.1016/j.jprot.2010.08.005.
18. Goo, Y.A., & Goodlett, D.R. (2010). Advances in proteomic prostate cancer biomarker discovery. Journal of Proteomics, 73, 1839-1850. doi:10.1016/j.jprot.2010.04.002.
19. Haack, M., Sanchez, E., & Mullington, J.M. (2007). Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep, 30, 1145-1152.
20. Halpert, A.D. (2010). Importance of early diagnosis in patients with irritable bowel syndrome. Postgraduate Medicine, 122, 102-111.
21. Heitkemper, M., Jarrett, M., Cain, K., Shaver, J., Bond, E., Woods, N.F., & Walker, E. (1996). Increased urine catecholamines and cortisol in women with irritable bowel syndrome. American Journal of Gastroenterology, 915, 906-913.
22. Hoshida, Y., Toffanin, S., Lachenmayer, A., Villanueva, A., Minguez, B., & Llovet, J.M. (2010). Molecular classification and novel targets in hepatocellular carcinoma: Recent advancements. Seminars in Liver Disease, 30, 35-51.
23. Hu, R.F., Jiang, X.Y., Zeng, Y.M. Chen, X.Y., & Zhang, Y.H. (2010). Effects of earplugs and eye masks on nocturnal sleep, melatonin and cortisol in a simulated intensive care unit environment. Critical Care, 14, R66.
24. James, G.D., Gastrich, H.J., Valdimarsdottir, H.B., & Bovberg, D.H. (2008). The rate of urinary cortisol excretion at work is persistently elevated in women at familial risk for breast cancer. American Journal of Human Biology, 20, 478.
25. Jarrett, M.E., Burr, R., Cain, K.C., Rothermel, J.D., Landis, C.A., & Heitkemper, M.M. (2008). Autonomic nervous system function during sleep among women with irritable bowel syndrome. Digestive Diseases and Sciences, 53, 694-703.
26. Jarrett, M.E., Kohen, R., Cain, K.C., Burr, R.L., Navaja, G.P., & Heitkemper, M.M. (2009). Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biological Research for Nursing, 9, 161-169.
27. Jia, L., Zhang, L., Shao, C., Song, E., Sun, W., Li, M., & Gao, Y. (2009). An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes. PloS One, 4, e5146.
28. Julian, B.A., Suzuki, H., Suzuki, Y., Tomino, Y., Spasovski, G., & Novak, J. (2009). Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease. Proteomics Clinical Applications, 3, 1029-1043.
29. Kasper, C.E. (2007). Genomics and proteomics methodologies for vulnerable population research. Annual Review of Nursing Research, 25, 191-217.
30. Kentsis, A. (2010). Challenges and opportunities for discovery of disease biomarkers using urine proteomics. Pediatric International. Advance online publication. doi:10.1111/j.1442-200X.2010. 03253.x.
31. Klugman, K.P., Madhi, S.A., & Albrich, W.C. (2008). Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clinical Infectious Disease, 47, S202-S206.
32. Kohen, R., Cain, K.C., Mitchell, P.H., Becker, K., Buzaitis, A., Millard, S.P., Veith, R. (2008). Association of serotonin transporter gene polymorphisms with poststroke depression. Archives of General Psychiatry, 65, 1296-1302.
33. Kopetzki, E., Lehnert, K., & Buckel, P. (1994). Enzymes in diagnostics: Achievements and possibilities of recombinant DNA technology. Clinical Chemistry, 40, 688-704.
34. Lovejoy, N.C., Thomas, M.L., Halliburton, P., & Mimnaugh, L. (1987). Tumor markers: Relevance to clinical practice. Oncology Nursing Forum, 14, 75-82.
35. McQuirter, M., Castiglia, L.L., Loiselle, C.G., & Wong, N. (2010). Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy. Oncology Nursing Forum, 37, 313-320.
36. Metcalfe, K.A., Poll, A., Royer, R., Liacuachaqui, M., Tulman, A., Sun, P., & Narod, S.R. (2010). Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. Journal of Clinical Oncology, 28, 387-391.
37. Mir, M., Homs, A., & Samitier, J. (2009). Integrated electrochemical DNA biosensors for lab-on-a-chip devices. Electrophoresis, 30, 3386-3397.
38. Mitchell, E.S., Farin, F.M., Stapleton, P.L., Tsai, J.M., Tao, E.Y., Smith-DiJulio, K., & Woods, N.F. (2008). Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause, 15, 105-111.
39. Panchaud, A., Scherl, A., Shaffer, S.A., von Haller, P.D., Kulasekara, H.D., Miller, S.I., & Goodlett, D.R. (2009). Precursor acquisition independent from ion count: How to dive deeper into the proteomics ocean. Annals of Chemistry, 81, 6481-6488.
40. Pejcic, M., Stojnev, S., & Stefanovic, V. (2010). Urinary proteomics-A tool for biomarker discovery. Renal Failure, 32, 259-268.
41. Pitteri, S.J., Hanash, S.M., Aragaki, A., Amon, L.M., Chen, L., Busald, B.T., & Prentice, R.L. (2009). Postmenopausal estrogen and progestin effects on the serum proteome. Genome Medicine, 1, 121.
42. Pottiez, N., Haverland, P., & Ciborowski, P. (2010). Mass spectrometric characterization of glesolin isoforms. Rapid Communications in Mass Spectrometry, 15, 2620.
43. Schmidt, A., & Aebersold, R. (2006). High-accuracy proteome maps of human body fluids. Genome Biology, 7, 242.
44. Schmidt, A., Claassen, M., & Aebersold, R. (2009). Directed mass spectrometry: Towards hypothesis-driven proteomics. Current Opinion in Chemical Biology, 13, 510-517.
45. Sigdel, T.K., & Sarwal, M.M. (2008). The proteogenomic path towards biomarker discovery. Pediatric Transplantation, 12, 737-747.
46. Simpson, K.L., Whetton, A.D., & Diver, C. (2009). Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification. Journal of Chromatography, B 877, 1240-1249.
47. Snow, A., Gozal, D., Valdes, R., & Jortani, S.A. (2010). Urinary proteins for the diagnosis of obstructive sleep apnea syndrome. Methods in Molecular Biology, 641, 223-241.
48. Sobhani, K. (2010). Urine proteomic analysis: Use of two-dimensional gel electrophoresis, isotope coded affinity tags, and capillary electrophoresis. Methods in Molecular Biology, 641, 325-346.
49. Thomas, K.A. (2009). 6-sulfatoxymelatonin collected from infant diapers: Feasibility and implications for urinary biochemical markers. Biological Research for Nursing, 11, 288-292.
50. Thompson, H., & Voss, J.G. (2009). Health and disease-related biomarkers in aging research. Research in Gerontological Nursing, 2, 137-145.
51. Waikar, S.S., Sabbisetti, V.S., & Bonventre, J.V. (2010). Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney International, 78, 486-494. doi:10.1038/ki.2010.165.
52. Woods, N.F., & Mitchell, E.S. (2010). Sleep symptoms during the menopausal transition and early postmenopause: Observations from the Seattle Midlife Women's Health Study. Sleep, 33, 539-549.
53. Zimmerli, L.U., Schiffer, E., Zurbig, P., Good, D.M., Kellmann, M., Mouls, L., Dominiczak, A.F. (2008). Urinary proteomic biomarkers in coronary artery disease. Molecular & Cellular Proteomics, 7, 290-298.